Elevated levels of IL-2, IL-9, and IL-15 driven by Tax lead to activate the Jak3/STAT5 pathway, and Jak3 inhibitor was shown to reduce in vitro immune activation in PBMCs from HAM/TSP patients (Ju et al., 2011). The gene discussed is JAK3; the disease is tropical spastic paraparesis.